RNS Number:6447M
XTL Biopharmaceuticals Limited
23 June 2003

                                  SCHEDULE 11

          NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

 1. Name of Company

    XTL Biopharmaceuticals Limited

 2. Name of Directors


Glenn Kazo

Elkan Gamzu

Martin Becker

Rusi Kathoke

Geoffrey Vernon

Patricia Smith


 3) Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a non
    beneficial interest or in the case of an individual holder if it is a
    holding of that person's spouse or children under the age of 18 or in
    respect of a non-beneficial interest

As 2 Above

4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)

As 2 Above

5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)

As 2 Above

6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary

Market Purchase

7) Number of shares/amount of Stock acquired

Glenn Kazo 125,000

Elkan Gamzu 10,000

Martin Becker 60,000

Rusi Kathoke 10,000

Geoffrey Vernon 50,000

Patricia Smith 50,000



8) Percentage of issued class

Glenn Kazo 125,000 (0.11%)

Elkan Gamzu 10,000 (0.01%)

Martin Becker 60,000 (0.05%)

Rusi Kathoke 10,000 (0.01%)

Geoffrey Vernon 50,000 (0.04%)

Patricia Smith 50,000 (0.04%)


9) Number of shares/amount of stock disposed

N/A

10) Percentage of issued class
N/A

11) Class of security

Ordinary Shares of IIs 0.02 each


12) Price per share

10p


13) Date of transaction

23 June 2003


14) Date company informed


23 June 2003

15) Total holding following this notification


Glenn Kazo 135,000

Elkan Gamzu 40,000

Martin Becker 860,000

Rusi Kathoke 15,000

Geoffrey Vernon 70,000

Patricia Smith 60,000


16) Total percentage holding of issued class following this notification

Glenn Kazo 135,000 (0.12%)

Elkan Gamzu 40,000 (0.04%)

Martin Becker 860,000 (0.77%)

Rusi Kathoke 15,000 (0.13%)

Geoffrey Vernon 70,000 (0.06%)

Patricia Smith 60,000 (0.05%)



24) Name of contact and telephone number for queries

Jonathan Burgin +972 8930 4444

25) Name and signature of authorised company official responsible for
making this notification


        Julie Howe 0207 020 5107

Date of Notification

     23 June, 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSMGGZVFFNGFZM